More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-5 of 5 results

  • www.activebiotech.com
  • 5
  • 3
  • 5
Tasquinimod is in clinical development for hematological malignances. A phase Ib/IIa study of tasquinimod in relapsed refractory multiple myeloma is ongoing... Our project portfolio comprises small, orally active immunomodulatory molecules as well..
Relevance: 22.070572
  • www.activebiotech.com
  • 5
  • 3
  • 5
Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory eye diseases. The project portfolio comprises both small, orally active immunomodulatory..
Relevance: 22.070572
  • www.4dpharmaplc.com
  • 4
  • 11
From asthma to cancer, we conduct world-leading research to identify live biotherapeutics with drug-like functionality to treat a range of diseases... We are uniquely positioned to rapidly translate our research into regulated, safe and efficacious..
Relevance: 15.818236
  • ryvu.com
  • 6
  • 2
  • 12
Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel small molecule therapies that address emerging targets in oncology... Ryvu Therapeutics was founded in 2007 and currently we employee approximately 260..
Relevance: 13.450851
  • cddf.org
  • 1
  • 2
  • 14
For many years, the Cancer Drug Development Forum (CDDF) has focused on developing initiatives that accelerate effective drug development in oncology treatment, reduce time to market, and improve patient access... The CDDF offers workshops,..
Relevance: 12.254049